13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 65 holding rows worth $275,353,000.
- Accession
- 0001826434-21-000002
- Filer
- CIK 1826434
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 65 entries on the cover page, a total value of $275,353,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $275,353,000 with VALUE read as thousands by filing date, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 478160104 | COM | 162,633 | $25,595,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 298,721 | $23,969,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 204,138 | $23,913,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 193,223 | $20,704,000 | thousands by filing date | |
| VIATRIS INC COM | 92556V106 | Stock | 1,046,794 | $19,617,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 441,324 | $17,600,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 54,105 | $11,013,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 166,077 | $10,283,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 55,521 | $9,374,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 62,235 | $8,423,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 73,906 | $8,289,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 23,374 | $7,505,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 271,974 | $7,237,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 121,409 | $6,945,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 67,384 | $5,861,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 259,283 | $5,227,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 10,423 | $5,035,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 40,159 | $4,635,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 296,838 | $4,366,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 56,003 | $4,297,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 69,932 | $3,638,000 | thousands by filing date | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 39,226 | $3,381,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 64,378 | $3,214,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 300,000 | $3,201,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 56,402 | $3,068,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 360,697 | $2,954,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 157,403 | $2,832,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 118,833 | $2,643,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 728,710 | $2,609,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 19,832 | $1,700,000 | thousands by filing date | |
| ONCTERNAL THERAPEUTICS INC | 68236P107 | COM | 285,714 | $1,400,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F500 | COM PAR | 658,373 | $1,369,000 | thousands by filing date | |
| 9 METERS BIOPHARMA INC | 654405109 | COM | 1,390,821 | $1,195,000 | thousands by filing date | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 26,722 | $1,159,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 40,910 | $1,130,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 39,225 | $950,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 49,373 | $877,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 7,178 | $688,000 | thousands by filing date | |
| Procter & Gamble Co | 742718109 | COM | 3,210 | $447,000 | thousands by filing date | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 9,630 | $445,000 | thousands by filing date | |
| Mondelez International,Inc. Class A | 609207105 | COM | 6,608 | $386,000 | thousands by filing date | |
| COLGATE PALMOLIVE CO COM | 194162103 | Stock | 4,343 | $371,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 62,000 | $356,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 10,283 | $330,000 | thousands by filing date | |
| Verizon Communications Inc | 92343V104 | COM | 5,437 | $319,000 | thousands by filing date | |
| Costco Wholesale Corporation | 22160K105 | COM | 841 | $317,000 | thousands by filing date | |
| KIMBERLY-CLARK CORP COM | 494368103 | Stock | 2,291 | $309,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 3,631 | $297,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 1,695 | $297,000 | thousands by filing date | |
| HORMEL FOODS CORP COM | 440452100 | Stock | 6,148 | $287,000 | thousands by filing date | |
| GENERAL MILLS INC COM | 370334104 | Stock | 4,799 | $282,000 | thousands by filing date | |
| HERSHEY CO COM | 427866108 | Stock | 1,842 | $281,000 | thousands by filing date | |
| CHURCH & DWIGHT CO INC COM | 171340102 | Stock | 3,185 | $278,000 | thousands by filing date | |
| KELLANOVA | 487836108 | COM | 4,416 | $275,000 | thousands by filing date | |
| MCCORMICK & CO INC COM NON VTG | 579780206 | Stock | 2,863 | $274,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 4,197 | $260,000 | thousands by filing date | |
| CLOROX CO DEL | 189054109 | COM | 1,234 | $249,000 | thousands by filing date | |
| BCE INC COM NEW | 05534B760 | Stock | 5,825 | $249,000 | thousands by filing date | |
| TELUS CORPORATION COM | 87971M103 | Stock | 11,793 | $234,000 | thousands by filing date | |
| FLOWERS FOODS INC COM | 343498101 | Stock | 10,182 | $230,000 | thousands by filing date | |
| UNILEVER PLC | 904767704 | SPON ADR NEW | 3,725 | $225,000 | thousands by filing date | |
| THE CAMPBELLS COMPANY COM | 134429109 | Stock | 4,432 | $214,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 17,260 | $129,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 15,618 | $65,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 14,557 | $51,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-21-000002 | this filing | 2021-02-16 | acceptance time not in the bulk data set |